Analysts have been eager to weigh in on the Healthcare sector with new ratings on Amylyx Pharmaceuticals Inc (AMLX – Research Report), Wave Life Sciences (WVE – Research Report) and GoodRx Holdings (GDRX – Research Report).
Amylyx Pharmaceuticals Inc (AMLX)
In a report issued on May 9, Marc Goodman from Leerink Partners maintained a Hold rating on Amylyx Pharmaceuticals Inc, with a price target of $4.00. The company’s shares closed last Monday at $1.82, close to its 52-week low of $1.70.
According to TipRanks.com, Goodman is a 4-star analyst with an average return of
The word on The Street in general, suggests a Hold analyst consensus rating for Amylyx Pharmaceuticals Inc with a $4.25 average price target, representing a 136.1% upside. In a report issued on May 9, Robert W. Baird also maintained a Hold rating on the stock with a $3.00 price target.
See the top stocks recommended by analysts >>
Wave Life Sciences (WVE)
Mizuho Securities analyst Salim Syed maintained a Buy rating on Wave Life Sciences on May 9 and set a price target of $19.00. The company’s shares closed last Monday at $5.69.
According to TipRanks.com, Syed has currently 0 stars on a ranking scale of 0-5 stars, with an average return of
Currently, the analyst consensus on Wave Life Sciences is a Strong Buy with an average price target of $12.20, implying an 113.3% upside from current levels. In a report issued on May 10, H.C. Wainwright also maintained a Buy rating on the stock with a $15.00 price target.
GoodRx Holdings (GDRX)
Leerink Partners analyst Michael Cherny assigned a Buy rating to GoodRx Holdings on May 9 and set a price target of $11.00. The company’s shares closed last Monday at $6.70.
According to TipRanks.com, Cherny is a 3-star analyst with an average return of
Currently, the analyst consensus on GoodRx Holdings is a Moderate Buy with an average price target of $9.12, implying a 37.8% upside from current levels. In a report issued on May 9, Wells Fargo also maintained a Buy rating on the stock with a $10.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on AMLX:
